MUMBAI, India, May 30 -- Intellectual Property India has published a patent application (202527034387 A) filed by Cipla Limited, Maharashtra, on April 8, for 'a pharmaceutical composition of salbutamol and pharmaceutical green propellant.'
Inventor(s) include Rote Kiran; and Bhadauria Pradeep.
The application for the patent was published on May 30, under issue no. 22/2025.
According to the abstract released by the Intellectual Property India: "Disclosed is a pharmaceutical composition for inhalation comprising salbutamol or enantiomer or salt or ester thereof and a pharmaceutically acceptable green propellant. Particularly disclosed is a pharmaceutical composition for inhalation comprising salbutamol or enantiomer or salt or ester thereof and a pharmaceutically acceptable green propellant HFA 152a and/or HFO 1234ze(E). Also disclosed processes of preparing such compositions."
The patent application was internationally filed on Aug. 09, 2023, under International application No.PCT/IN2023/050762.
Disclaimer: Curated by HT Syndication.